Biomimetic proopiomelanocortin suppresses capsaicin-induced sensory irritation in humans

Research in Pharmaceutical Sciences

Volumn 11, Issue 6, 2016, Pages 484-490

  Fatemi, Sayed Ali ^a   Jafarian Dehkordi, Abbas ^a   Hajhashemi, Valiollah ^a   Asilian Mahabadi, Ali ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti irritation; Biomimetic peptides; Contact dermatitis; Neurocosmetics; Proopiomelanocortin; Sensitive skin

Indexed keywords

CAPSAICIN; LIPOPEPTIDE; PLACEBO; PROOPIOMELANOCORTIN; STRONTIUM CHLORIDE;

ACUTE DISEASE; ADULT; ARTICLE; BIOMIMETICS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE; SKIN IRRITATION; SKIN PROTECTION; SKIN SENSITIVITY; VOLUNTEER;

EID: 85014245235     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: 10.4103/1735-5362.194890     Document Type: Article

References (43)

1. Farage M, Katsarou A, Maibach H. Sensory, clinical and physiological factors in sensitive skin: a review. Contact Dermatitis. 2006;55(1):1-14.
2. Pons-Guiraud A. Sensitive skin: a complex and multifactorial syndrome. J Cosmet Dermatol. 2004;3(3):145-148.
3. Kligman A, Sadiq I, Zhen Y, Crosby M. Experimental studies on the nature of sensitive skin. Skin Res Technol. 2006;12(4):217-222.
4. Lupo M, Cole A. Cosmeceutical peptides. Dermatol Ther. 2007;20(5):343-349.
5. Zhang L, Falla TJ. Cosmeceuticals and peptides. Clin Dermatol. 2009;27(5):485-494.
6. Xie Y, Rizzi SC, Dawson R, Lynam E, Richards S, Leavesley DI, et al. Development of a threedimensional human skin equivalent wound model for investigating novel wound healing therapies. Tissue Eng Part C Methods. 2010;16(5):1111-1123.
7. Fuller RW, Conradson TB, Dixon CM, Crossman DC, Barnes PJ. Sensory neuropeptide effects in human skin. Br J Pharmacol. 1987;92(4):781-788.
8. Lintner K, Mas-Chamberlin C, Mondon P, Peschard O, Lamy L. Cosmeceuticals and active ingredients. Clin Dermatol. 2009;27(5):461-468.
9. Slominski A, Wortsman J, Paus R, Elias PM, Tobin DJ, Feingold KR. Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech. 2008;5(2):137-144.
10. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183-200.
11. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000;21(5):457-487.
12. Zouboulis CC. Human skin: an independent peripheral endocrine organ. Horm Res. 2000;54(5-6):230-242.
13. Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol. 2003;149(2):79-90.
14. Luger TA, Scholzen T, Brzoska T, Becher E, Slominski A, Paus R. Cutaneous immunomodulation and coordination of skin stress responses by alphamelanocyte-stimulating hormone. Ann N Y Acad Sci. 1998;840:381-394.
15. Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol. 2006;126(8):1697-1704.
16. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev. 2006;86(4):1309-1379.
17. Slominski A. Neuroendocrine system of the skin. Dermatology. 2005;211(3):199-208.
18. Millington GW. Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol. 2006;31(3):407-412.
19. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80(3):979-1020.
20. Bohm M, Luger TA. The role of melanocortins in skin homeostasis. Horm Res. 2000;54(5-6):287-293.
21. Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol. 2001;117(2):309-317.
22. Slominski A, Wortsman J, Tuckey RC, Paus R. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol. 2007;265-266:143-149.
23. Böhm M, Luger TA, et al. Cutaneous neuromodulation: the proopiomelanocortin system. Exp Clin Endocrinol Diabetes. 1999;107:225-228.
24. Luger TA. Neuromediators-A crucial component of the skin immune system. J Dermatol Sci. 2002;30(2):87-93.
25. Kondo S, Kono T, Sauder DN, McKenzie RC. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol. 1993;101(5):690-694.
26. Böhm M, Schulte U, Kalden H, Luger TA. Alphamelanocyte-stimulating hormone modulates activation of NF-κB and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann N.Y Acad Sci. 2006;885:277-286.
27. Clausen BE, Girard-Madoux M. IL-10 control of dendritic cells in the skin. Oncoimmunology. 2013;2(3):e23186.
28. Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha R. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest. 2003;112(7):1058-1066.
29. Nakagawa H, Hiura A. Capsaicin, transient receptor potential (TRP) protein subfamilies and the particular relationship between capsaicin receptors and small primary sensory neurons. Anat Sci Int. 2006;81(3):135-155.
30. Bode AM, Dong Z. The two faces of capsaicin. Cancer Res. 2011;71(8):2809-2814.
31. Schliemann S, Antonov D, Manegold N, Elsner P. The lactic acid stinging test predicts susceptibility to cumulative irritation caused by two lipophilic irritants. Contact Dermatitis. 2010;63(6):347-356.
32. Papoiu AD, Valdes-Rodriguez R, Nattkemper LA, Chan YH, Hahn GS, Yosipovitch G. A novel topical formulation containing strontium chloride significantly reduces the intensity and duration of cowhage-induced itch. Acta Derm Venereol. 2013;93(5):520-526.
33. Willis CM, Shaw S, De Lacharriere O, Baverel M, Reiche L, Jourdain R, et al. Sensitive skin: an epidemiological study. Br J Dermatol. 2001;145(2):258-263.
34. Diogo L, Papoila AL. Is it possible to characterize objectively sensitive skin? Skin Res Technol. 2010;16(1):30-37.
35. Dieamant Gde C, Velazquez Pereda Mdel C, Eberlin S, Nogueira C, Werka RM, Queiroz ML. Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment. J Cosmet Dermat. 2008;7(2):112-119.
36. Primavera G, Berardesca E. Sensitive skin: mechanisms and diagnosis. Int J Cosmet Sci. 2005; 27(1):1-10.
37. Misery L, Myon E, Martin N, Consoli S, Boussetta S, Nocera T, et al. Sensitive skin: psychological effects and seasonal changes. J Eur Acad Dermatol Venereol. 2007;21(5):620-628.
38. Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, et al. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol. 2006; 126(9):1937-1947.
39. Luger TA, Lotti T. Neuropeptides: Role in inflammatory skin diseases. J Eur Acad Dermatol Venereol. 1998;10(3):207-211.
40. Kono M, Nagata H, Umemura S, Kawana S, Osamura RY. In situ expression of corticotropinreleasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J. 2001;15(12):2297-2299.
41. Luger TA, Scholzen T, Grabbe S. The role of α-melanocyte-stimulating hormone in cutaneous biology. J Investig Dermatol Symp Proc. 1997;2(1):87-93.
42. Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev. 2004;56(1):1-29.
43. Hahn GS. Strontium is a potent and selective inhibitor of sensory irritation. Dermatol Surg. 1999;25(9):689-694.